Skip to the content
Search
Dulaglutide Peptide
Gastrointestinal disorders were also the most common reason for discontinuing treatment with semaglutide and dulaglutide.
Menu
CD162
Cevidoplenib
AXL
ART0380
Menu
Search
CD162
Cevidoplenib
: Pyrazine-Based Syk Kinase Inhibitors